A Review on the Prevalence and Treatment of Antibiotic Resistance Genes in Hospital Wastewater

Lihua Lan, Zhaoran Wang, Yuxin Chen, Ting Ting Wang, Jin Zhang, Biqin TanToxics 2025 · DOI

TL;DR

Hospital wastewater is a significant reservoir and disseminator of antibiotic resistance genes (ARGs) and antibiotic-resistant bacteria (ARB), posing a global health threat. This review synthesizes current knowledge on ARG prevalence in hospital wastewater compared to other sources and evaluates existing and emerging treatment methods, emphasizing the need for more effective strategies, especially in light of increased antibiotic use during the COVID-19 pandemic.

What Problem Does This Paper Address?

The paper addresses the critical and growing problem of antibiotic resistance (AR), a major global health threat responsible for millions of deaths annually. A key pathway for the spread of AR is through hospital wastewater (HWW), which acts as a concentrated source of clinically relevant antibiotic resistance genes (ARGs) and antibiotic-resistant bacteria (ARB). Unlike general municipal wastewater, HWW contains higher levels of these resistance determinants due to the intensive use of antibiotics in clinical settings. The paper aims to consolidate current understanding of ARG prevalence in HWW versus other environments, assess the effectiveness of current wastewater treatment methods in eliminating ARGs, and highlight the implications of the COVID-19 pandemic on this issue. Ultimately, it underscores the urgent need for improved HWW treatment to mitigate the environmental dissemination of ARGs.

Methods

This review synthesizes findings from numerous existing studies. The methodologies employed by the reviewed studies to identify and quantify ARGs and ARB include:

  • Culture-based methods: Traditional techniques involving selective media to isolate ARBs, followed by antibiotic susceptibility testing (e.g., disk diffusion, microdilution) to determine resistance profiles.
  • Molecular methods:
    • Conventional PCR: Used to detect the presence or absence of specific ARGs.
  • Quantitative PCR (qPCR): Employed to quantify ARGs using species-specific primers.
  • Digital PCR (dPCR): Utilized for absolute quantification of low-abundance ARBs with enhanced precision.
  • Metagenomics: A culture-independent approach that sequences total DNA from samples to identify ARGs within complex microbial communities. This allows for the characterization of ARG diversity, abundance, and potential horizontal gene transfer.

The review itself is a comprehensive literature synthesis, comparing data from various studies that utilized these methods to assess ARG and ARB prevalence in different wastewater types and evaluating the efficacy of various treatment strategies.

Datasets

Not discussed in the paper. The paper is a review of existing literature and does not present new experimental data or datasets.

Key Insights and Ideas

  • HWW as a Hotspot: Hospital wastewater is consistently shown to be a significantly more concentrated source of clinically important ARGs and ARB compared to municipal, community, or rural wastewater. This is driven by the high antibiotic usage in hospitals.
  • Specific ARGs of Concern: Critical ARGs like those conferring carbapenem resistance (e.g., blaNDM-1, blaKPC), methicillin resistance (mecA), vancomycin resistance (vanA), and extended-spectrum beta-lactamases (ESBLs) are found at much higher levels in HWW.
  • COVID-19 Amplified the Problem: The pandemic led to increased antibiotic use, even for viral infections, exacerbating the AR burden. COVID-19 isolation hospitals showed a significantly higher prevalence of ARGs (88.5%) compared to non-COVID-19 facilities.
  • Horizontal Gene Transfer (HGT) is Crucial: Mobile genetic elements (MGEs) and phages in HWW facilitate the transfer of ARGs between bacteria, increasing the risk of AR spread within environmental contexts.
  • Current Treatment Limitations: While conventional wastewater treatment methods (e.g., activated sludge, chlorination) can reduce ARGs, they are often inconsistent and may not completely eliminate them. Some methods even show negative removal rates for certain ARGs.
  • Emerging Technologies Show Promise: Advanced technologies like membrane bioreactors (MBRs), ozonation, and E-peroxone-SBR demonstrate better ARG reduction capabilities, but challenges like cost, complexity, and potential for regrowth remain.

Key Results

  • Carbapenem Resistance: blaNDM-1 prevalence in hospital settings was 71%, compared to 12% in community settings.
  • MRSA: The mecA gene was common in HWW (3.26 × 10⁷ copies/100 mL) and retirement home sewers but absent in municipal wastewater.
  • VRE: The vanA gene was found at 7.95 × 10¹ copies/100 mL in HWW, with hospitals contributing more than community sources.
  • ESBLs: Genes like blaCTX-M were more abundant in HWW (7.96 log copies/mL) than urban wastewater (6.86 log copies/mL).
  • Other Resistance: mcr-1 was detected in HWW (2.23 × 10⁴ copies/100 mL) but not in retirement homes.
  • Treatment Efficacy: Advanced technologies like MBRs and ozonation achieved over 3 log reductions for certain ARGs (e.g., blaSHV, ermB). The E-peroxone-SBR system effectively reduced qnrS and aac(6')-Ib-cr. However, chlorination, while reducing some ARGs, had negative removal rates for blaTEM-1 and tetB.

Limitations and Future Work

  • Incomplete Removal: Current wastewater treatment methods, even advanced ones, often fail to completely eliminate ARGs, leaving them to spread into the environment.
  • Cost and Scalability: Implementing advanced treatment technologies on a large scale is often hindered by high costs and the need for significant infrastructure.
  • Urban Constraints: The location of large hospitals in densely populated urban areas limits the available land for developing extensive on-site wastewater treatment facilities.
  • HGT and Pressure Selection: Advanced treatment methods themselves can sometimes induce error-prone DNA polymerases and promote HGT, potentially creating new resistance challenges.
  • Future Work: The authors emphasize the need for:
  • Developing more effective, cost-efficient, and sustainable treatment strategies.
  • Upgrading existing facilities and building on-site treatment equipment.
  • Developing innovative technologies with an emphasis on cost-efficiency and compatibility with existing infrastructure.
  • Formulating secure medical equipment for rapid and efficient HWW treatment during Public Health Emergencies of International Concern (PHEICs).
  • Continued monitoring of AMR progression, especially in low- to middle-income countries.
  • Further research into the prevalence of resistance genes and the evaluation of various effective treatment processes.

Summary updated

Abstract

Antibiotic resistance is a global environmental and health threat. Approximately 4.95 million deaths were associated with antibiotic resistance in 2019, including 1.27 million deaths that were directly attributable to bacterial antimicrobial resistance. Hospital wastewater is one of the key sources for the spread of clinically relevant antibiotic resistance genes (ARGs) into the environment. Understanding the current situation of ARGs in hospital wastewater is of great significance. Here, we review the prevalence of ARGs and antibiotic-resistant bacteria (ARB) in hospital wastewater and wastewater from other places and the treatment methods used. We further discuss the intersection between ARGs and COVID-19 during the pandemic. This review highlights the issues associated with the dissemination of critical ARGs from hospital wastewater into the environment. It is imperative to implement more effective processes for hospital wastewater treatment to eliminate ARGs, particularly during the current long COVID-19 period.
BibTeX
@inproceedings{lan2025review,
  author = {Lihua Lan and Zhaoran Wang and Yuxin Chen and Ting Ting Wang and Jin Zhang and Biqin Tan},
  title = {{A Review on the Prevalence and Treatment of Antibiotic Resistance Genes in Hospital Wastewater}},
  booktitle = {Toxics},
  year = {2025},
  doi = {10.3390/toxics13040263},
}
Figure